Separation of solubilized A2 adenosine receptors of human platelets from non-receptor [3H]NECA binding sites by gel filtration
- PMID: 2835689
- DOI: 10.1007/BF00169478
Separation of solubilized A2 adenosine receptors of human platelets from non-receptor [3H]NECA binding sites by gel filtration
Abstract
Human platelet membranes were solubilized with the zwitterionic detergent CHAPS (3-[3-(cholamidopropyl)-dimethylammonio]-1-propanesulfonate) and the solubilized extract subjected to gel filtration. Binding of the adenosine receptor agonist [3H]NECA (5'-N-ethylcarboxamidoadenosine) was measured to the eluted fractions. Two [3H]NECA binding peaks were eluted, the first of them with the void volume. This first peak represented between 10% and 25% of the [3H]NECA binding activity eluted from the column. It bound [3H]NECA in a reversible, saturable and GTP-dependent manner with an affinity of 46 nmol/l and a binding capacity of 510 fmol/mg protein. Various adenosine receptor ligands competed for the binding of [3H]NECA to the first peak with a pharmacological profile characteristic for the A2 adenosine receptor as determined from adenylate cyclase experiments. In contrast, most adenosine receptor ligands did not compete for [3H]NECA binding to the second, major peak. These results suggest that a solubilized A2 receptor-Gs protein complex of human platelets can be separated from other [3H]NECA binding sites by gel filtration. This allows reliable radioligand binding studies of the A2 adenosine receptor of human platelets.
Similar articles
-
Identification of a novel high affinity adenosine binding protein from bovine striatum.Naunyn Schmiedebergs Arch Pharmacol. 1992 Jul;346(1):63-8. doi: 10.1007/BF00167572. Naunyn Schmiedebergs Arch Pharmacol. 1992. PMID: 1407007
-
Ra adenosine receptors in human platelets. Characterization by 5'-N-ethylcarboxamido[3H]adenosine binding in relation to adenylate cyclase activity.Naunyn Schmiedebergs Arch Pharmacol. 1984 Mar;325(3):226-33. doi: 10.1007/BF00495948. Naunyn Schmiedebergs Arch Pharmacol. 1984. PMID: 6328333
-
Partial separation of platelet and placental adenosine receptors from adenosine A2-like binding protein.Mol Pharmacol. 1990 Apr;37(4):554-9. Mol Pharmacol. 1990. PMID: 2325637
-
[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.J Pharmacol Exp Ther. 1989 Dec;251(3):888-93. J Pharmacol Exp Ther. 1989. PMID: 2600819
-
Adenosine receptors in the central nervous system.J Neural Transm Suppl. 1991;34:149-55. doi: 10.1007/978-3-7091-9175-0_19. J Neural Transm Suppl. 1991. PMID: 1817158 Review.
Cited by
-
The A2 adenosine receptor: guanine nucleotide modulation of agonist binding is enhanced by proteolysis.Mol Pharmacol. 1991 Feb;39(2):130-5. Mol Pharmacol. 1991. PMID: 1899902 Free PMC article.
-
Chemical modification and irreversible inhibition of striatal A2a adenosine receptors.Mol Pharmacol. 1992 Jul;42(1):123-33. Mol Pharmacol. 1992. PMID: 1635550 Free PMC article.
-
Evidence for the involvement of cyclic GMP in adenosine-induced, age-dependent vasodilatation.Br J Pharmacol. 1990 Jul;100(3):569-75. doi: 10.1111/j.1476-5381.1990.tb15848.x. Br J Pharmacol. 1990. PMID: 2167736 Free PMC article.
-
Adenosine A1 and A2 receptors: structure--function relationships.Med Res Rev. 1992 Sep;12(5):423-71. doi: 10.1002/med.2610120502. Med Res Rev. 1992. PMID: 1513184 Free PMC article. Review. No abstract available.
-
Pharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]-CGS 21680 binding.Br J Pharmacol. 1996 Apr;117(8):1693-701. doi: 10.1111/j.1476-5381.1996.tb15341.x. Br J Pharmacol. 1996. PMID: 8732278 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources